SCHEMBL1564564

SCHEMBL1564564

CC(C)(C)N(C(=O)O)[C@H]1CCCCNC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 2/20 0.38
SLC6A11 P48066 1/20 0.38
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLC6A13 Q9NSD5 1/20 0.38
SLC6A2 P23975 9/20 0.35
SLC6A4 P31645 9/20 0.35
SLC6A3 Q01959 4/20 0.35
KCNH2 Q12809 3/20 0.34
CYP2D6 P10635 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
SSTR4 P31391 1/20 0.32
CPN1 P15169 1/20 0.31
CPB2 Q96IY4 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16763687 1.00 SLC6A1 (0.38) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL16763685 1.00 SLC6A1 (0.38) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL612826 0.95 SLC6A1 (0.43) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL124776 0.95 SLC6A1 (0.43) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL14632099 0.95 SLC6A1 (0.43) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL13719286 0.95 SLC6A1 (0.43) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL476847 0.88 SLC6A4 (0.37) SLC6A1SLC6A11SLC6A13SLC6A2SLC6A4
SCHEMBL1290220 0.88 SLC6A4 (0.37) SLC6A1SLC6A11SLC6A13SLC6A2SLC6A4
SCHEMBL743575 0.88 SLC6A4 (0.37) SLC6A1SLC6A11SLC6A13SLC6A2SLC6A4
SCHEMBL28715568 0.80 KDM4E (0.44) SLC6A1SLC6A11TSHRLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2305671-A1 Thiophene and thiazole derivatives as CHK1 inhibitors AstraZeneca AB (SE) 2011-04-06 EP disclosed